| NCT06522035 | Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis | RECRUITING | PHASE1 | 2024-08-01 | 2026-09 | 2026-03 |
| NCT06233474 | Study of Intra-articular Allocetra in Knee Osteoarthritis | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2024-01-26 | 2026-02-01 | 2025-09-15 |
| NCT04659304 | Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19 | UNKNOWN | PHASE1 | 2021-12 | 2022-12 | 2022-09 |
| NCT04922957 | A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) | TERMINATED | PHASE2 | 2021-09-01 | 2024-03-11 | 2022-04-01 |
| NCT04612413 | A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients | COMPLETED | PHASE2 | 2020-11-30 | 2024-12-16 | 2024-01-12 |
| NCT03925857 | Prevention of Sepsis-related Organ Dysfunction With Allocetra-OTS | COMPLETED | PHASE1 | 2019-01-27 | 2020-01-12 | 2019-12-10 |